AKT1 and Alzheimer disease: Our results emphasized that MS mainly involves catalytic function, enzyme interaction, and AD-related pathways, affecting vital proteins such as AKT1, GSK3B, NFκB1, and BACE1, which play significant roles in AD therapy.